Feldan’s mission is to be a premium provider of ancillary materials such as clinical grade cytokines and transcription factors critical to the development and application of cell therapy.
Feldan is also developing a breakthrough technology based on Shuttle Proteins for the translocation of transcription factors and genome editing techniques.